Literature DB >> 18188576

T/NK cell lymphoma presenting as a "blocked nose".

Naomi Ketharanathan1, Peter Jan van Kipshagen, Wies Vasmel, Ellis Barbé, Nico de Vries.   

Abstract

We present the case of a 63-year-old Caucasian male who complained of persistent rhinitis and sinusitis accompanied by a total left-sided nasal blockage. The diagnosis nasal T/NK cell lymphoma was established by histopathological investigation. This case was diagnosed as stage IE lymphoma as no other sites were involved. The patient was treated with CHOP (cyclophosfamide, doxorubicin, vincristin and prednisone) chemotherapy and involved-field radiotherapy. The nasal T/NK cell lymphoma is a rare malignancy, which is known to have an extremely aggressive and destructive course. The mainstay of treatment is locoregional radiotherapy combined with chemotherapy, depending on disease stage. A high index of clinical suspicion is imperative to ensure early diagnosis and ultimately improve disease outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18188576     DOI: 10.1007/s00405-007-0578-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  14 in total

Review 1.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Authors:  B D Cheson; S J Horning; B Coiffier; M A Shipp; R I Fisher; J M Connors; T A Lister; J Vose; A Grillo-López; A Hagenbeek; F Cabanillas; D Klippensten; W Hiddemann; R Castellino; N L Harris; J O Armitage; W Carter; R Hoppe; G P Canellos
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

Review 2.  T/NK cell non-Hodgkin's lymphoma of the sinonasal tract.

Authors:  P Sheahan; M Donnelly; S O'Reilly; M Murphy
Journal:  J Laryngol Otol       Date:  2001-12       Impact factor: 1.469

3.  Aggressive peripheral T-cell lymphomas (specified and unspecified types).

Authors:  Kerry J Savage
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

Review 4.  Sinonasal malignant lymphomas: a distinct clinicopathological category.

Authors:  R W Vidal; K Devaney; A Ferlito; A Rinaldo; A Carbone
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-04       Impact factor: 1.547

Review 5.  Idiopathic midline destructive disease: fact or fiction.

Authors:  Juan Pablo Rodrigo; Carlos Suárez; Alessandra Rinaldo; Kenneth O Devaney; Antonino Carbone; Leon Barnes; Dennis K Heffner; Alfio Ferlito
Journal:  Oral Oncol       Date:  2005-04       Impact factor: 5.337

Review 6.  Natural killer-cell malignancies: diagnosis and treatment.

Authors:  Y-L Kwong
Journal:  Leukemia       Date:  2005-12       Impact factor: 11.528

Review 7.  Staging non-Hodgkin lymphoma.

Authors:  James O Armitage
Journal:  CA Cancer J Clin       Date:  2005 Nov-Dec       Impact factor: 508.702

8.  Non-Hodgkin's lymphoma of the sinonasal tract.

Authors:  M S Quraishi; E M Bessell; D Clark; N S Jones; P J Bradley
Journal:  Laryngoscope       Date:  2000-09       Impact factor: 3.325

9.  Sinonasal NK/T-cell lymphomas in the United States.

Authors:  K Gaal; N C Sun; A M Hernandez; D A Arber
Journal:  Am J Surg Pathol       Date:  2000-11       Impact factor: 6.394

10.  Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases.

Authors:  S L Abbondanzo; B M Wenig
Journal:  Cancer       Date:  1995-03-15       Impact factor: 6.860

View more
  3 in total

1.  Rhino-Orbital-Cerebral Mycosis and Extranodal Natural Killer or/and T-Cell Lymphoma, Nasal Type.

Authors:  Dong Ming Li; Li De Lun
Journal:  Front Med (Lausanne)       Date:  2022-06-17

Review 2.  Mucor irregularis infection and lethal midline granuloma: a case report and review of published literature.

Authors:  Dong Ming Li; Li De Lun
Journal:  Mycopathologia       Date:  2012-06-29       Impact factor: 2.574

3.  Extranodal nasal-type NK/T-cell lymphoma of the palate and paranasal sinuses.

Authors:  Nikitakis Nikolaos; Polyzois Grigorios; Katoumas Konstantinos; Titsinides Savvas; Zolota Vassiliki; Sklavounou Alexandra; Papadas Theodoros
Journal:  Am J Case Rep       Date:  2012-05-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.